Home Business J&J Covid vaccine recipients are better off getting Pfizer or Moderna booster, NIH study suggests

J&J Covid vaccine recipients are better off getting Pfizer or Moderna booster, NIH study suggests

1 min read
0
0
9

Pfizer-BioNTech Covid-19 vaccines at a senior living facility in Worcester, Pennsylvania, U.S., on Wednesday, Aug. 25, 2021.

Hannah Beier | Bloomberg | Getty Images

Johnson & Johnson Covid-19 vaccine recipients are better off getting a booster shot from Pfizer or Moderna, a highly anticipated U.S. study suggested Wednesday.

The study on “mixing and matching” Covid vaccines included more than 450 adults who have received one of the three regimens currently available in the United States: J&J’s, Moderna’s or Pfizer’s. The study hasn’t yet been peer-reviewed.

This is a developing story. Please check back for updates.


Source link

Load More Related Articles
Load More By The Texas Chronicle
Load More In Business

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

Tesla (TSLA) shares hit all-time high

Tesla CEO Elon Musk gestures as he visits the construction site of Tesla’s Gigafacto…